By RTE Reporter at 10:20amOn Friday, the Irish Government announced a plan to fund research into a new treatment for gallstones that has been used successfully for the treatment of Crohn’s disease.

It will be one of the first drug trials to be funded through the National Health Service.

It’s the first time that the Mayo Clinic has funded a treatment for ocular or ocular and ocular, ocular cyst, ophthalmic and ophthalmological conditions.

Gardasil was approved by the European Medicines Agency last year.

The drug works by preventing cells from multiplying and growing in the eye.

It is used to treat meningitis, herpes, hepatitis C and other conditions that cause inflammation of the lining of the eye and can cause the eye to swell or fall out.

The new treatment will not cure all types of ocular conditions.

It also prevents ovaries from developing normally.

The drug will not affect the reproductive function of women.

The drugs maker said the drug would not affect menopause, as there was no indication of any long-term effects from the treatment.

In a statement, it said the drugs drug had been approved in the US and Europe and had been developed by a UK company.

It added that the new drug was a “world first” and would be “one of the largest ever drugs trials funded by the Irish Health Service”.

The drugs company said the new treatment was being funded by a public-private partnership with the Irish Department of Health, the Department of Science and Technology and the National Institute for Health Research.

Its a world first, and the results are very exciting, Dr James McPherson, chief medical officer at Mayo Clinic, told the Irish Independent.

The Irish Government has set a target of raising €1bn from the Medicines Fund.

It has also pledged to spend up to €1.5bn on research into other ocular diseases.

In May, the UK government announced that it would fund £2.5 billion worth of research into ocular cancer drugs.

In December, it announced that the National Cancer Research Centre in the UK would fund an extra €1 billion for the research.

It said the fund would be used to develop “other exciting, life-saving treatments for cancer”.

“This is a historic moment for Ireland,” said Minister for Health Simon Harris.

“Our government is committed to ensuring that Irish patients can have access to a quality and safe medication that will help them live longer, healthier and happier lives.

We know that this is a long and expensive road to get to where we need to be and it will take some time to complete the trials.

But we are determined to get there.”